Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.

Oranite GoldratGeraldine Van Den SteenEric Gonzalez-MerinoJulie DechèneChristine GervyAnne DelbaereFabienne DevrekerViviane De MaertelaerIsabelle Demeestere

Published in: Reproductive biology and endocrinology : RB&E (2019)

Clinicaltrials.gov - NCT02661932 , registered 25 January 2016, retrospectively registered.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
polycystic ovary syndrome
chronic kidney disease
prognostic factors
type diabetes
metabolic syndrome
patient reported outcomes
insulin resistance